Long-term outcomes and clinical impact of anti-HLA donor-specific antibodies (DSA) after liver transplantation: a prospective study in a pilot cohort.

Aranzazu Caballero MarcosRaquel Díaz RuizMario Romero CristóbalAinhoa Fernández YunqueraFernando Díaz-FontenlaLeticia Pérez CarazoMaría Isabel Peligros GómezJosé Luis Vicario MorenoMagdalena Salcedo PlazaRafael Bañares Cañizares

Published in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2021)

the incidence of DSA is high after LT. In addition, the persistence of de novo DSA could be associated with silent liver fibrosis with a potential impact on graft outcomes.

Keyphrases

liver fibrosis
risk factors
study protocol
human health
randomized controlled trial
clinical trial
adipose tissue
metabolic syndrome
risk assessment